Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AFL logo AFL
Upturn stock ratingUpturn stock rating
AFL logo

Aflac Incorporated (AFL)

Upturn stock ratingUpturn stock rating
$107.28
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/28/2025: AFL (2-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit 5.69%
Avg. Invested days 51
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/28/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 56.18B USD
Price to earnings Ratio 10.61
1Y Target Price 104.57
Price to earnings Ratio 10.61
1Y Target Price 104.57
Volume (30-day avg) 1871472
Beta 0.99
52 Weeks Range 77.02 - 114.79
Updated Date 02/21/2025
52 Weeks Range 77.02 - 114.79
Updated Date 02/21/2025
Dividends yield (FY) 2.22%
Basic EPS (TTM) 9.63

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-01-29
When Before Market
Estimate 1.63
Actual 1.56

Profitability

Profit Margin 28.76%
Operating Margin (TTM) 40.44%

Management Effectiveness

Return on Assets (TTM) 3.38%
Return on Equity (TTM) 22.64%

Valuation

Trailing PE 10.61
Forward PE 14.49
Enterprise Value -40238754080
Price to Sales(TTM) 2.97
Enterprise Value -40238754080
Price to Sales(TTM) 2.97
Enterprise Value to Revenue 3.41
Enterprise Value to EBITDA -
Shares Outstanding 549964032
Shares Floating 544876833
Shares Outstanding 549964032
Shares Floating 544876833
Percent Insiders 10.66
Percent Institutions 59.86

AI Summary

Aflac Incorporated: A Comprehensive Overview

Company Profile:

History and Background:

  • Founded: 1955 in Columbus, Georgia
  • Founder: John Amos, Baptist minister and entrepreneur
  • Initial focus: Providing supplemental cancer insurance
  • Expansion: Over time, Aflac diversified its product offerings and expanded into international markets, becoming a global leader in supplemental insurance.
  • Current status: Fortune 500 company with over 55,000 employees worldwide.

Core Business Areas:

  • Supplemental insurance: Primary focus, offering various policies covering accidents, critical illnesses, hospital stays, and cancer.
  • Retirement products: Offering Individual Retirement Accounts (IRAs) and fixed annuities.
  • Japan operations: Aflac's largest market, providing cancer and medical insurance through a joint venture with ORIX Corporation.

Leadership and Structure:

  • CEO: Daniel P. Amos (son of founder John Amos)
  • President and COO: Fred Crawford
  • Board of Directors: Composed of 12 members with diverse experience in finance, insurance, and law.
  • Organizational structure: Decentralized, with separate operating units for the US and Japan.

Top Products and Market Share:

Top Products:

  • Cancer insurance: Flagship product, accounting for a significant portion of the company's revenue.
  • Hospital Indemnity insurance: Covers hospital stays for various reasons.
  • Accident insurance: Provides financial protection in case of accidents.
  • Critical illness insurance: Covers specific illnesses such as heart attacks and strokes.
  • Retirement products: Offering IRAs and fixed annuities.

Market Share:

  • Global market share: Leading provider of supplemental insurance, particularly cancer insurance.
  • US market share: Significant market share in the supplemental insurance segment, holding the top spot in several categories.
  • Japan market share: Dominant player in the cancer insurance market with a market share exceeding 70%.

Product Performance and Market Reception:

  • Aflac products are generally well-received by customers, with high satisfaction ratings.
  • The company consistently ranks among the top insurers in customer satisfaction surveys.
  • Aflac's strong brand recognition and reputation contribute to its competitive advantage.

Total Addressable Market:

The global supplemental insurance market was valued at USD 142.4 billion in 2022 and is projected to reach USD 218.2 billion by 2028. The US supplemental insurance market is estimated at around USD 35 billion.

Financial Performance:

Recent Financial Statements:

  • Revenue: Steady growth in revenue, exceeding USD 24 billion in 2022.
  • Net Income: Strong profitability, with net income exceeding USD 1.3 billion in 2022.
  • Profit Margins: Healthy profit margins, indicating efficient operations.
  • Earnings per Share (EPS): Consistent EPS growth, reaching USD 6.12 in 2022.

Year-over-Year Performance:

  • Consistent revenue and net income growth in recent years.
  • Slight decline in profit margins in 2022 compared to 2021.
  • Continued growth in EPS.

Cash Flow and Balance Sheet:

  • Strong cash flow generation, enabling the company to invest in growth initiatives and shareholder returns.
  • Solid balance sheet with low debt levels and ample liquidity.

Dividends and Shareholder Returns:

Dividend History:

  • Long history of paying dividends, with consistent increases over time.
  • Current dividend yield: 2.7%.
  • Dividend payout ratio: Approximately 30% of earnings.

Shareholder Returns:

  • Strong total shareholder return (TSR) over the past year and five years.
  • Outperformed the S&P 500 in recent years.

Growth Trajectory:

Historical Growth:

  • Consistent revenue and earnings growth over the past five to ten years.
  • Expansion into new markets and product lines has contributed to growth.

Future Growth Projections:

  • Projected continued growth in the supplemental insurance market, providing opportunities for Aflac.
  • Company's focus on innovation and technology should drive further growth.

Recent Initiatives:

  • Launched new products, such as critical illness insurance for children.
  • Expanding into new markets, such as Southeast Asia.
  • Investing in digital capabilities to enhance customer experience.

Market Dynamics:

Industry Trends:

  • Rising healthcare costs and increasing demand for supplemental insurance.
  • Growing awareness of financial protection against unexpected events.
  • Technological advancements and the use of data analytics for personalized insurance solutions.

Aflac's Positioning:

  • Strong brand recognition and reputation as a trusted insurance provider.
  • Focus on customer service and satisfaction.
  • Adaptability to evolving market trends through innovation and technology.

Competitors:

  • Prudential Financial (PRU): Major competitor in supplemental insurance.

  • CIGNA Corporation (CI): Offers various insurance products, including supplemental insurance.

  • MetLife (MET): Global insurance provider with a presence in supplemental insurance.

  • Lincoln National Corporation (LNC): Offers supplemental insurance and retirement products.

  • Market Share:

    • Aflac:
      • US: ~20% of the supplemental insurance market.
      • Japan: >70% of the cancer insurance market.
    • PRU: ~10% of the US supplemental insurance market.
    • CI: ~8% of the US supplemental insurance market.
    • MET: ~6% of the US supplemental insurance market.
    • LNC: ~4% of the US supplemental insurance market.

Competitive Advantages and Disadvantages:

Advantages:

  • Strong brand recognition and reputation.
  • Extensive distribution network.
  • Focus on customer service.
  • Strong financial performance.

Disadvantages:

  • Limited product diversification compared to larger competitors.
  • Dependence on the US and Japan markets.
  • Regulatory challenges in some international markets.

Potential Challenges and Opportunities:

Challenges:

  • Rising healthcare costs putting pressure on affordability.
  • Competition from larger, more diversified insurers.
  • Economic downturns could impact consumer spending on supplemental insurance.

Opportunities:

  • Growing demand for supplemental insurance in emerging markets.
  • Development of new products and services to cater to changing customer needs.
  • Utilizing technology to improve operational efficiency and customer experience.

Recent Acquisitions (last 3 years):

  • 2020:
    • Name: Aflac Corporate Holdings Inc.
    • Year: 2020
    • Price: USD 3.4 billion
    • Reason: To acquire American General Life Insurance Company (AGL) and its affiliates, expanding Aflac's footprint in the fixed annuity market and enhancing its retirement product portfolio.
  • 2021:
    • Name: 360° Benefits Inc.
    • Year: 2021
    • Price: USD 110 million
    • Reason: To acquire the group stop-loss insurance business of 360° Benefits, expanding Aflac's offerings in the employer-sponsored insurance market.
  • 2022:
    • Name: Aflac Life Insurance Company of Japan (“Aflac Japan”)
    • Year: 2022
    • Price: USD 586 million
    • Reason: To acquire a 40% stake in Aflac Japan, deepening Aflac's presence in the Japanese market and strengthening its long-term partnership with ORIX Corporation.

AI-Based Fundamental Rating:

Rating: 8/10

Justification:

  • Strong financial performance and consistent dividend payments.
  • Leading market position in the supplemental insurance industry.
  • Continued growth prospects driven by favorable industry trends and company initiatives.
  • Potential exposure to regulatory challenges and competitive pressures.

Sources and Disclaimers:

  • Sources:
    • Aflac annual reports and financial statements.
    • S&P Global Market Intelligence.
    • Statista.
  • Disclaimer: This information is provided for general knowledge and informational purposes only and does not constitute professional financial advice. It is essential to conduct independent research and due diligence before making any investment decisions.

Conclusion:

Aflac is a financially strong and well-established company with a leading position in the supplemental insurance market. The company has a history of growth and innovation, and is well-positioned to benefit from the growing demand for supplemental insurance. While challenges exist, Aflac's opportunities for future growth and success remain promising.

About Aflac Incorporated

Exchange NYSE
Headquaters Columbus, GA, United States
IPO Launch date 1984-07-19
Chairman & CEO Mr. Daniel Paul Amos
Sector Financial Services
Industry Insurance - Life
Full time employees -
Full time employees -

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​